Home/Kivu Bioscience/Daniel O’Connell, MD, PhD
DO

Daniel O’Connell, MD, PhD

Board Chair, Partner at Novo Holdings

Kivu Bioscience

Roles

Board Chair, Partner at Novo HoldingsatKivu Bioscience
AdvisoratCassidy Bio
Chief Executive OfficeratAcumen Pharmaceuticals

Therapeutic Areas

Kivu Bioscience Pipeline

DrugIndicationPhase
KIVU-107Solid tumorsIND-Enabling
KIVU-305Solid tumorsIND-Enabling
KIVU-495Solid tumorsIND-Enabling
KIVU-202Solid tumorsDevelopment Candidate